Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neurologic Manifestations × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 189 Breast Neoplasms 107 Neoplasms 78 Prostatic Neoplasms 31 Fatigue 26 Obesity 21 Colorectal Neoplasms 18 Lung Neoplasms 14 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Colonic Neoplasms 12 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 9 Multiple Myeloma 8 Lymphedema 8 Hematologic Neoplasms 8 Brain Neoplasms 8 Weight Loss 7 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Bevacizumab 4 Temozolomide 3 Irinotecan 3 Sorafenib 2 Radiosurgery 2 pembrolizumab 1 ibrutinib 1 Vorinostat 1 Valproic Acid 1 Therapeutics 1 Thalidomide 1 Sildenafil Citrate 1 Radiotherapy 1 Pliability 1 Plasma Exchange 1 Nivolumab 1 Morphine 1 Methadone 1 Lenalidomide 1 Immunoglobulins 1 Exercise 1 Carboplatin 1 Bendamustine Hydrochloride 1 Amifampridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡